Biofrontera Inc. Files Definitive Proxy Statement
Ticker: BFRIW · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1858685
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
TL;DR
Biofrontera filed its proxy statement, shareholders vote soon.
AI Summary
Biofrontera Inc. filed its definitive proxy statement on April 30, 2025, for the fiscal year ending December 31, 2024. The company, headquartered in Woburn, MA, is seeking shareholder approval for matters related to its annual meeting. This filing is a standard procedural document required for publicly traded companies.
Why It Matters
This filing provides shareholders with crucial information regarding upcoming votes and company governance, allowing them to make informed decisions about their investment.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial performance data or strategic changes.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the proxy statement.)
- 20250430 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- 0001858685 (company) — Central Index Key
- 120 Presidential Way, Suite 330, Woburn, MA 01801 (company) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is a document filed with the SEC by a company that is soliciting shareholder votes on specific matters, such as the election of directors or executive compensation.
When is Biofrontera Inc.'s fiscal year end?
Biofrontera Inc.'s fiscal year ends on December 31.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 30, 2025.
Where is Biofrontera Inc. headquartered?
Biofrontera Inc. is headquartered at 120 Presidential Way, Suite 330, Woburn, MA 01801.
What is the SIC code for Biofrontera Inc.?
The Standard Industrial Classification (SIC) code for Biofrontera Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Biofrontera Inc. (BFRIW).